北京大学学报(医学版) ›› 2021, Vol. 53 ›› Issue (4): 814-817. doi: 10.19723/j.issn.1671-167X.2021.04.034
• 病例报告 • 上一篇
ZHOU Guang-ping1,ZHOU Qian-yun2,Δ(),ZHU Ji-hong1
中图分类号:
[1] |
Takai K, Nikkuni K, Momoi A, et al. Thrombocytopenia with reticulin fibrosis accompanied by fever, anasarca and hepatosplenomegaly: A clinical report of five cases [J]. J Clin Exp Hematop, 2013, 53(1):63-68.
doi: 10.3960/jslrt.53.63 |
[2] |
Castleman B, Towne VW. Case records of the Massachusetts General Hospital: Case No.40231 [J]. N Engl J Med, 1954, 250(23):1001-1005.
doi: 10.1056/NEJM195406102502308 |
[3] |
Castleman B, Iverson L, Menendez VP. Localized mediastinal lymphnode hyperplasia resembling thymoma [J]. Cancer, 1956, 9(4):822-830.
doi: 10.1002/(ISSN)1097-0142 |
[4] |
Kojima M, Nakamura S, Nishikawa M, et al. Idiopathic multicentric Castleman’s disease. A clinicopathologic and immunohistochemical study of five cases [J]. Pathol Res Pract, 2005, 201(4):325-332.
doi: 10.1016/j.prp.2005.01.006 |
[5] |
Kojima M, Nakamura N, Tsukamoto N, et al. Clinical implications of idiopathic multi centric castleman disease among Japanese: A report of 28 cases [J]. Int J Surg Pathol, 2008, 16(4):391-398.
doi: 10.1177/1066896908315812 |
[6] |
Fajgenbaum DC, Uldrick TS, Bagg A, et al. International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease [J]. Blood, 2017, 129(12):1646-1657.
doi: 10.1182/blood-2016-10-746933 pmid: 28087540 |
[7] |
Iwaki N, Fajgenbaum DC, Nabel CS, et al. Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV-8-negative multicentric Castleman disease [J]. Am J Hematol, 2016, 91(2):220-226.
doi: 10.1002/ajh.24242 |
[8] |
Igawa T, Sato Y. TAFRO syndrome [J]. Hematol Oncol Clin North Am, 2018, 32(1):107-118.
doi: 10.1016/j.hoc.2017.09.009 |
[9] |
Masaki Y, Kawabata H, Takai K, et al. Proposed diagnostic criteria, disease severity classification and treatment strategy for TAFRO syndrome [J]. Int J Hematol, 2016, 103(6):686-692.
doi: 10.1007/s12185-016-1979-1 |
[10] |
Kikuchi T, Shimizu T, Toyama T, et al. Successful treatment of TAFRO syndrome with tocilizumab, prednisone, and cyclophosphamide [J]. Intern Med, 2017, 56(16):2205-2211.
doi: 10.2169/internalmedicine.8522-16 |
[11] |
Yamaga Y, Tokuyama K, Kato T, et al. Successful treatment with cyclosporin A in tocilizumab-resistant TAFRO syndrome [J]. Intern Med, 2016, 55(2):185-190.
doi: 10.2169/internalmedicine.55.4710 |
[12] |
Shirai T, Onishi A, Waki D, et al. Successful treatment with tacrolimus in TAFRO syndrome [J]. Medicine, 2018, 97(23):e11045.
doi: 10.1097/MD.0000000000011045 |
[13] | 王素霞, 邹古明, 章友康, 等. Castleman病肾损害的临床病理分析 [J]. 中华肾脏病杂志, 2009, 25(8):585-590. |
[14] |
Kawashima M, Usui T, Okada H, et al. TAFRO syndrome: 2 cases and review of the literature [J]. Mod Rheumatol, 2017, 27(6):1093-1097.
doi: 10.3109/14397595.2015.1059982 pmid: 26052800 |
[1] | 潘佳忻,朱赛楠,李双玲,王东信. 副肿瘤性天疱疮合并实体肿瘤的危重症患者术后远期结局的影响因素[J]. 北京大学学报(医学版), 2022, 54(5): 981-990. |
[2] | 周鑫,李文智. 肾细胞癌极致保肾时代的冷思考[J]. 北京大学学报(医学版), 2022, 54(4): 595-598. |
[3] | 安文成,闫慧娴,邓正照,陈芳,欧小虹,金红心,黄薇. 原发性醛固酮增多症肾上腺切除术后慢性肾功能不全1例[J]. 北京大学学报(医学版), 2021, 53(6): 1201-1204. |
[4] | 李西慧,肖锋,张思宇. 不停跳冠状动脉旁路移植术后急性肾损伤的影响因素探讨及3年随访结果[J]. 北京大学学报(医学版), 2017, 49(1): 131-136. |
[5] | 陈亮, 李建兴, 杨波, 胡卫国, 黄晓波, 王晓峰. 不同肾造瘘管及固定方式对肾结石合并肾功能不全患者术后并发症的影响[J]. 北京大学学报(医学版), 2011, 43(6): 878-881. |
[6] | 陈亮, 李建兴, 黄晓波, 杨波, 王佳, 王晓峰. 肾结石合并肾功能不全患者围手术期尿微量白蛋白与尿肌酐比值检测及意义[J]. 北京大学学报(医学版), 2011, 43(5): 757-760. |
[7] | ACS-PCI患者肾功能状态调查协作组, 霍勇, 何华. 急性冠状动脉综合征接受介入治疗患者肾功能状态多中心注册研究[J]. 北京大学学报(医学版), 2007, 39(6): 624-629. |
|